Literature DB >> 2759931

Determination of serum and bone concentrations of cephradine and cefuroxime by HPLC in patients undergoing hip and knee joint replacement surgery.

D A Leigh1.   

Abstract

Bone and serum concentrations of cephradine and cefuroxime were measured by HPLC in 21 patients undergoing hip and knee joint replacement surgery. An intravenous dose of 750 mg of each cephalosporin was given to patients at induction of anaesthesia. The serum and bone concentrations of both compounds were similar in individual patients although there was considerable interpatient variation. The mean concentrations in the femoral head bone supernatant in hip replacements were 7.2 mg/kg of cephradine and 8.0 mg/kg of cefuroxime. In knee replacement the femoral condyle bone concentrations were 5.1 mg/kg of cephradine and 4.2 mg/kg of cefuroxime, and for tibial bone 5.6 and 4.6 mg/kg respectively. Both cephradine and cefuroxime diffuse well into bone giving bone concentrations effective against common pathogens such as Staphylococcus aureus and S. epidermidis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2759931     DOI: 10.1093/jac/23.6.877

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  4 in total

1.  [Perioperative antibiotic prophylaxis in hip operations. Penetration into bone, capsule tissue and cartilage exemplified by cefuroxime].

Authors:  A Katzer; J V Wening; P Kupka; N M Meenen; K H Jungbluth
Journal:  Unfallchirurgie       Date:  1997-08

2.  [Possibilities for the use of the basic cephalosporin cefuroxime in bone surgery. Tissue levels, effectiveness and tolerance].

Authors:  R Ketterl; W Wittwer
Journal:  Infection       Date:  1993       Impact factor: 3.553

Review 3.  Methicillin-resistant staphylococci in clean surgery. Is there a role for prophylaxis?

Authors:  E Mini; S Nobili; P Periti
Journal:  Drugs       Date:  1997       Impact factor: 9.546

Review 4.  Penetration of antibacterials into bone: pharmacokinetic, pharmacodynamic and bioanalytical considerations.

Authors:  Cornelia B Landersdorfer; Jürgen B Bulitta; Martina Kinzig; Ulrike Holzgrabe; Fritz Sörgel
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.